Optimal surveillance of hepatocellular carcinoma in patients with chronic viral hepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 7, 2001, Pages 715-717

  Lin, Deng Yn ^a   Liaw, Yun Fan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

AGE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOGRAPHY; EDITORIAL; ETHNIC GROUP; HEALTH CARE COST; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; VIRUS HEPATITIS;

EID: 0035720759     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02511.x     Document Type: Editorial

References (28)

1. Hepatocellular carcinoma
2. Risk factors for the rising rates of primary liver cancer in the United States
3. Non-surgical treatment of hepatocellular carcinoma
4. Early detection of hepatocellular carcinoma by real-time ultrasonography
5. Early detection of hepatocellular carcinoma in patients with type B hepatitis. A prospective study
6. Effectiveness of periodic check up by ultrasonography for the early diagnosis of hepatocellular carcinoma
7. Early diagnosis of hepatocellular carcinoma
8. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis
9. Mass screening for hepatocellular carcinoma: Experience in Hokkaido, Japan
10. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan
11. Risk factors of hepatocellular carcinoma with familial tendency
12. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients
13. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer
14. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population
15. Effectiveness of regular surveillance of hepatocellular carcinoma in haemochromatosis with cirrhosis
16. Efficacy of surveillance for hepatocellular carcinoma in HCV cirrhotic patients
17. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis
18. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
19. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America
20. Alpha-fetoprotein changes in the course of chronic hepatitis: Relation to bridging hepatic necrosis and hepatocellular carcinoma
21. Tumor-marker levels and prognosis in malignant teratoma of testis
22. The fucosylation index of alpha-fetoprotein as a possible prognostic indication for patients with hepatocellular carcinoma
23. Serum alpha fetoprotein in the early stage of human hepatocellular carcinoma
24. Growth rate of symptomatic hepatocellular carcinoma and its clinical implications
25. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
26. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers
27. Age-related, different clinicopathologic features of hepatocellular carcinoma patients
28. Screening for hepatocellular carcinoma